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Several interleukins have previously been implied in some action on B cell
responses (1-17). Two of us (Karasuyama, H., and F. Melchers, submitted for
publication) have established mouse cell lines by transfection with a bovine pap-
illoma virus-based expression vector carrying full-length cDNAs encoding either
IL-2, IL-3, IL-4, or IL-5 that secrete high quantities of these interleukins. In
this paper, we test single interleukins and chosen combinations ofthem for their
activity to mature resting B lymphocytes without proliferation (18) and to prop-
agate proliferation of activated B cell blasts at one of three possible restriction
points in the B cell cycle (19).
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Materials and Methods
Conditioning of Tissue Culture Media with and Partial Purification by DEAE-Cellulose
Chromatography ofMouse Interleukin (mIL)`-2, -3, -4, and -5. X63-Ag8-653 plasmacytoma
cells transfected with the BMGNeo vector containing either mIL-2, -3, -4, or -5 cDNA
were grown in serum-containing medium for 48 h and the culture supernatants were
collected as conditioned media. The cells were then washed extensively and, thereafter,
incubated for 48 hr at 1-2 X 106 cells/ml in either medium containing transferrin, BSA,
and lipids or in medium with no serum, supplemented with only transferrin in concen-
trations used in the serum-substituted media (20). The conditioned media resulting from
these incubations were collected and used as described in Results. Media with only trans-
ferrin conditioned by the transformants containing between 102 and 10" U/ml of the
corresponding interleukins, were dialyzed against distilled water. 1 liter of dialyzed
medium was run over a 1 X 5-cm DEAE-cellulose column (DE52, equilibrated with 10-3
M K-phosphate, pH 8) and the adsorbed protein and IL activity was eluted with a linear
gradient from 10-j to 0.25 M K-phosphate, pH 8. Fractions were assayed for IL activities
as described (Karasuyama, H. and F. Melchers, submitted for publication), and active
fractions were pooled and used as partially purified IL preparations. An example of an
elution profile for IL-5 from DEAE-cellulose similar to that given by Takatsu et al. (21)
is shown in Fig. 1 . Upon examination of these partially purified IL preparations in SDS-
PAGE, it became evident that they were still contaminated by transferrin and by other
proteins. They are, therefore, considered to be only partially purified.
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to 10- w M K-phosphate, pH 8. The adsorbed protein and IL-5 activity was eluted with a
linear gradient from 10' M to 0.25 M K-phosphate, pH 8.0. IL-5 activity was assayed as
described in this paper by maturation without proliferation of small, resting B cells (see Mate-
rials and Methods).
In Vitro Culture ofResting and Activated B Cells..
￿
Spleen cells of C57BL/6 nu/nu mice
(6-8 wk old, either from the Institut fur Biologisch-Medizinische Forschung AG, Fiil-
linsdorf, Switzerland; or from G. Bomholtgaard, Ry, Denmark) were first purified for
small resting cells by velocity sedimentation (22) . The resting cells were cultured at 5 X
106 cells/ml with IL preparations as specified in Results. Supernatants containing the
anti-IL-2-R rnAbs PC 61 (23) and 7D4 (24) were added to some of these cultures. The
development of Ig-secreting cells was monitored by the protein A plaque-forming
(PFC) assay (25), and their potential proliferation was monitored by uptake of radi
thymidine. [sH]Thymidine uptake was determined at day 2 of culture by a 4-h pulse
1 yCi per culture of a [sH]thymidine solution with 2 Ci/mmol (The Radiochemical
Centre, Amersham, United Kingdom). For limiting dilution analysis, small resting
C57BL/6 nu/nu spleen cells were cultured in the presence of 3 X 106/ml rat thymocytes
as fillers (31) and 10% IL-5-conditioned medium. The development of IgM-secreting
cells was monitored on day 5 of culture.
B cell blasts were generated from resting B cells by a 2-d stimulation with LPS (25
Ag/ml, S-form, kindly given to us by Dr. O. Luderitz and Ch. Galanos, Max-Planck-Insti-
tut fur Immunbiologie, Freiburg, Federal Republic of Germany) and 10% B cell growth
factor a (BCGF-a)-conditioned medium. BCGF-a-conditioned medium was prepared by
stimulation of confluent P388DI macrophage line cells for 48 h with 2 ug/ml LPS (26).
The resulting B cell blasts were removed from the tissue culture bottles without shaking,
allowing for additional accessory (A) cell depletion due to the sticking ofA cells to plastic
surfaces. The cells were then washed twice at room temperature with warm tissue culture
medium, sedimented under earth gravity, and blast cells were collected for reculture
(19). Blasts were recultured at ^-5 X 104 cells/ml. Throughout the in vitro experiments,
serum-substituted tissue culture medium (20) was used. Cell concentrations in culture
were determined by counting with the aid of a hemocytometer (Bfrker, Rieger, Basil,
Switzerland). A rat mAb with specificity for 1 heavy chains, Ak8, (27) was coupled to
Sepharose 4B at 2.5 mg/ml under conditions described previously (28). The beads were
used at 0,3-0.5% in culture. OBCGF-containing material was a G100-Sephadex gel chro-
matography fraction of an (NH4)2S04-precipitated medium conditioned by Con A-acti-
vated rat spleen cells depleted of BCGF-a activity, described previously (19). It was used
at 2% in culture.Results
B Cell Maturation Activity of IL-2, -3, -4, or -5.
￿
Resting B lymphocytes appear
to have the capacity to mature to Ig-secreting cells even in the absence of pro-
liferation when they are exposed to factors that are secreted by helper T cells
and A cells in their Ag-specific, MHC-restricted interactions (18, 29). These fac-
tors were termed B cell maturation factors (BMF). The nonreplicating, blast-like,
Ig-secreting cells lost their capacity to be induced to proliferate by polyclonal
activators, such as LPS, as they matured. Full maturation to IgM-, IgG-, and
IgA-secreting cells was observed within 5 d of culture.
To test whether a single IL could induce this maturation without prolifera-
tion, we exposed resting B cells to the IL-conditioned media as well as to IL
preparations that were partially purified by DEAE-cellulose chromatography as
described in Materials and Methods. The results shown in Fig. 2 indicate that
IL-3 and IL-4 are inactive as BMF, while IL-2 and IL-5 are active. No synergism
was observed for these activities when all possible combinations of two, three,
and four different ILs at 104-fold different ranges of concentrations were tested
(data not shown) . The highest concentrations tested were 30% of the condi-
tioned media and 10 Ag/ml of partially purified preparations of the four ILs.
IL-5, however, was at least 101 times more active as BMF than IL-2, assuming
that the two IL preparations tested, either as conditioned media or as partially
purified protein preparations, contained approximately the same quantities of
IL molecules. These results suggest that IL-5 is the major BMF, inducing mat-
uration of resting B cells without proliferation. A more stringent test for the
induction of small resting B cells to maturation without proliferation is shown
below.
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FIGURE 2. Maturation without proliferation
to IgM-PFC of small resting C57BL/6J nu/nu
splenic B cells in the presence of different
concentrations of mIL-2 (IM, mIL-3 (A), mIL-
4 (V), and mIL-5 (O,",®). IgM PFC were
assayed at day 5 of culture. Proliferation
assayed by uptake of radioactive thymidine was
at most 5,000 sH cpm incorporated by 105
plated cells in any of the cultures, compared
with 75,000 sH cpm incorporated by the same
number of LPS-stimulated cells, all at day 2 of
culture. Media were conditioned in serum-sub-
stituted medium for 24-48 h by X63-Ag8-653
transformants (1-2 X 105/ml) carrying single
mIL-cDNA genes (M,A,V,"). Conditioning was
1b-1
￿
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i0-3
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10-4
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also done in serum-free medium containing
Dilution of IL-conditioned medium* o, ", A*
￿
only transferrin (O), from which mIL-5 was
partially purified by DEAE-cellulose chroma-
104 103 102 10O 10o 1e
￿
tography (®) as described in Materials and
nglml DEAE-cellulose purified protein (®)
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TABLE I
Anti-IL-2-R Antibodies Block IL-2-induced, but not IL-5-induced,
Maturation of Small Resting C57BL/6,J nu/nu Splenic B Cells
Maturation of small
resting B cells to
Antibodies added
￿
IgM-PFC induced by:
to cultures
IL-2* IL-5"
None
￿
355 280
Anti-II-2-RI
￿
32 485
102 U/ml. The number of IgM-PFC was determined at day 5 of culture.
" Conditions as in Fig. 4.
4A 10% mix of mAbs PC61 and 7D4.
mAbs PC61 and 7D4 with specificity for the murine IL-2-R inhibited the
development of IgM PFC induced by IL-2, but failed to do so in the PFC devel-
opment induced by IL-5 (Table I). This suggests that induction of maturation
without proliferation by the two ILs is mediated by different receptors, and that
IL-2 uses the IL-2-R on B cells to do so.
B Cell Proliferation-Propagating Activity of IL-2, -3, -4 or -5.
￿
When B cells are
excited from their resting state, they become susceptible to the synergistic pro-
liferation-propagating activity of the two types of B cell growth factors, called
BCGF-a and BCGF-0 (19). It was previously shown that Ig-specific antibodies
insolubilized on Sepharose beads (28) act early in the G, phase of every succes-
sive cell cycle to allow B cell blasts to become reactive to BCGF-a (19). BCGF-
a acts late in the G, phase and thereby controls the entry into S phase and Gz
phase. At this point, BCGF-0 becomes active to stimulate B cell blasts into mito-
sis. The cell cycle of activated B cells is, therefore, controlled by three restriction
points. This dissection of the cell cycle has provided assay systems that allow the
characterization of a given IL as a given B cell proliferation-propagating activity.
Media conditioned by cells producing one of the four ILs and the partially
purified preparations of these ILs obtained by DEAE-cellulose chromatography
were, therefore, tested for activities replacing either Ig-specific antibodies,
BCGF-a or BCGF-0 in B cell cycle control. Data in Table II show that neither
IL-2, -3, -4, nor -5 can replace either Ig-specific antibodies or BCGF-a in their
synergistic proliferation-propagating activities with activated B cell blasts . IL-3
and IL-4, in fact, do not show any B cell proliferation-propagating activities, as
they are also inactive in replacing BCGF-0. IL-2 and IL-5, on the other hand,
can both replace BCGF-(3. It is evident from the data in Fig. 3 that both IL-2
and IL-5 have BCGF-0 activities that are comparable; i .e., act at the same low
concentrations. Here, we assume again that the conditioned media (as well as
the partially purified preparations) contain the same amounts of IL-2 and IL-5.
When data presented in Fig. 2 are compared with those in Fig. 3, it becomes
evident that half-maximal BCGF-0 activity of both IL-2 and IL-5 was obtained
at concentrations at which half-maxmal BMF activity of IL-5 was observed . No
significant synergism was observed for B cell proliferation-promoting activities
of IL-2 or IL-5 when all possible combinations of two, three, and four differentKARASUYAMA ET AL.
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TABLE II
Proliferation ofLPS-activated, Purified C57BL/6f nulnu Splenic B Cell Blasts
5 X 104 velocity sedimentation-purified C57BL/6J nu/nu LPS-activated B cell blasts permilliliter
cultured and counted on day 3 of restimulation as described in Materials and Methods. Positive
responses are underlined.
a, BCGF-<x;#, BCGF-8; anti-Ig, Ig-specific mAb Ak8coupledto Sepharose. Numbersin table must
be multiplied by 104 to obtain the number of cellspermilliliter in culture.Fordetails, seeMaterials
and Methods.
* 1% of mediaconditioned by the appropriate transformants, as describedin Materialsand Methods.
ILs were tested at 104-fold different ranges of concentrations (data not shown),
Filler Effects of mIL-2, -3, -4, or -5 in In Vitro Cultures ofProliferating and Matur-
ing B Cells. The efficiency of cells initiating proliferation in cultures of poly-
clonally stimulated murine splenic B lymphocytes is cell density dependent (30) .
Below 105 cells/ml, this efficiency starts to drop, so that below 104 cells/ml LPS-
Fi(;URE: 3.
￿
Proliferation of LPS-activated B cell
blasts in the presence of Ig-specific antibodies
plus aBCGF and different concentrations of mIL
Dilution of IL-conditioned medium 1r, o, w. A,v1
￿
2 (W, mIL-3 (A), mIL-4 (7), and mIL-5 (",O,O).
Preparations of the mlLs were those described in
104 103 102 t0'
￿
1,00 10-,
￿
Fig. 2. Cells were counted after 65 h of culture
ngtmlDEAE-cellulose purified proteinW
￿
with the aid of a heniocytometer (Barker).
Factors further
added to
culture* None a ,i3
Factors
Anti-Ig
originally in
Anti-Ig -h a
culture*
Anti-Ig + 0 Anti-Ig + a -t- j3
None 7 8 11 10 13 15 75
IL-2 8 9 12 15 85 18 ND
IL-3 8 9 10 10 15 15 ND
IL-4 8 7 10 9 14 16 ND
11-5 9 9 12 14 80 18 ND
LPS 14 68 20 ND ND ND ND1382
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or anti-Ig-induced proliferation can no longer be observed . The drop in effi-
ciency is measurable as the ratio of uptake of radioactive thymidine by prolif-
erating B cells over the number of B cells plated (Fig . 4 a) . The efficiency of
cells initiating polyclonal proliferation upon suitable stimulation is drastically
increased to near 100% by the addition of "filler" cells, such as rat thymus cells
(31) . This has allowed the growth and maturation of single, mitogen-stimulated
B cell clones in vitro .
Media conditioned by cells producing one of the four ILs, as well as the par-
tially purified preparations of these ILs, were tested for their capacity not only
to synergize in cell cycle control of activated B cells, but also to act as filler
activities in polyclonally stimulated B cell cultures . Data in Fig . 4 a show that
neither IL-3 nor IL-4 had such activities with either LPS- or anti-Ig-stimulated
splenic B cells . In fact, none of the ILs were able to act in this filler capacity in
LPS-stimulated B cell cultures . IL-2, as well as IL-5, however, did so, measura-
ble down to 50-100 cells per cultures in anti-Ig-stimulated B cell cultures . We
FIGURE 4 . (a) Filler effects of
mIL-2 and mIL-5 in cultures of
B cells stimulated to proliferation
in the presence of Ig-specific
antibodies and BCGF-oc . mIL-2
(0,/), mIL-3, mIL-4 (,n,,V ; data
for IL-3 was indistinguishable
from those with IL-4), and mIL-
5 (O,") were contained in serum-
substituted media (20) condi-
tioned by X63-Ag8-653 plasma-
cytoma cells transfected with
BMGNeo vectors containing the
appropriate mIL-cDNA . They
were used at 1% in culture. 200-
j1 cultures containing serial dilu-
tions of C57BL/6J nu/nu small
resting B cells were stimulated
with either LPS + BCGF-«
(" ,",V) or Ig-specific antibodies
plus aBCGF (O,l],A), and
uptake of radioactive thymidine
into stimulated cells were deter-
mined as described in Materials
and Methods. (b) Induction of
IgM PFC assayed at day 5 of cul-
ture in 200 Al of serum-substi-
tuted medium by IL-5 (1% of a
conditioned medium [see a])
alone (") or by IL-5 in the pres-
ence of rat thymus cells (5 X
10"/ml, A) of small spleen cells
of C57BL/6J nu/nu mice . Con-
trols are in medium alone (O) or
medium containing rat thymus
cells both with the highest
concentration of small spleen
cells cultured . Lewis-strain rats
(4-6 wk old) were obtained from
the Institut fur Biologisch-Medi-
zinische Forschung AG .KARASUYAMA ET AL .
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conclude from these results that IL-2 and IL-5 will not only act as BCGF-a activ-
ity in anti-Ig-stimulated B cells, but also serve as filler activity, which enhances
the efficiency of plating of anti-Ig-stimulated B cells by a factor of >102 .
We also tested the capacity of IL-5 to induce small splenic B cells to matura-
tion without proliferation at concentrations of 5 X 105 cells/ml or below in the
presence or absence of thymus filler cells. Data in Fig. 4 b show that IL-5
induced a constant ratio of IgM PFC over plated small cells in the presence, as
well as in the absence, of rat filler cells, measurable down to concentrations of
5 X 102 cells/ml, while no maturation was observed without IL-5 at any cell
concentration tested . In these measurements it should, however, be realized that
the lower the number of cells assayed, the higher the potential error in the
determination of thymidine uptake and in the number of PFC. Thus, 100 cells
yield an average of only 50 cpm, respectively, 15 PFC over background . In con-
clusion, these results indicate that the "filler" effect of rat thymus cells can also
be observed when small B cells mature to secreting cells without proliferation,
and that this high efficiency of B cell maturation is also observed with IL-5
alone ; i.e ., in the absence of filler cells.
The Frequency of Resting B Cells that Mature without Proliferation .
￿
From the
data presented so far, is is not proven that single resting B cells induced by IL-
2 or IL-5 mature without division . The residual uptake of radioactive thymidine
observed in these assays (^-10% of that induced by the polyclonal activator LPS
at day 2 of stimulation) could indicate that a minor population within our prep-
aration of resting B cells could proliferate and mature to IgM-PFC, giving rise
within the 5 d of culture to single clones with -30 cells, all of which might
divide and secrete IgM as larger numbers of resting B cells do when stimulated
with LPS (30) . Maturation without proliferation of larger numbers of resting B
cells, on the other hand, would lead to a clone size of one IgM PFC from one
FIGURE 5 .
￿
Limiting dilution analy-
sis of resting small C57BL/6J nu/nu
splenic B cells to respond to IL-5 (A)
and to LPS (B) by proliferation and
maturation to IgM PFC . (A) Cul-
tures of 0.2 ml contained 50 small
resting C57BL/6J nu/nu spleen
cells, 6 X 10 - ' rat thymocytes and
10% IL-5-conditioned medium with
>5 X 10" U . IgM PFC were deter-
mined on day 5 of culture . Cultures
with 5 IgM PFC are plotted . Fre-
quency of precursors induced by IL-
5 giving clone sizes of IgM PFC sim-
ilar to those induced by LPS (B) as
predictedby Poisson's distribution is
1 in 1,500-3,000 . (B) Cultures of
0.2 ml contained 3 small resting
C57BL/6J nu/nu spleen cells, 6 X
105 rat thymocytes, and 50 wg/ml
LPS . IgM PFC were determined on
day 5 of culture . Frequency of pre-
cursors induced by LPS forming
IgM PFC predictedby Poisson's dis-
tribution is l in 10 .1384
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TABLE III
Limiting Dilution Analysis of the Number ofResting B Cells Responding to IL-5 by Maturation
without Proliferation to IgM PFC
* Cultures of 0.2 ml contained 50 small restingC57BL/6J nu/nu spleen cells, 6 X I0' rat thymocytes,
and 10% IL-5-conditioned medium with 5 X 10' U/ml, all in serum-substituted media (20). Assays
for IgM PFC were done with the protein A plaque assay on day 5 of culture (25).
§ The clone sizes of cultures with >5 IgM PFC are shown in Fig. 5.
" Calculated on the basis that ^- 70% of all resting small cells of C57BL./6J nu/nu were found to be
surface Ig+.
precursor. These two alternate possibilities can be tested experimentally in lim-
iting dilution analyses. Since limiting dilution analyses must be done under tissue
culture conditions where the efficiency of plating of precursors is near 100%
(31), rat filler cells must be used in the cultures. This then limited the analysis
to IL-5 induction of resting B cells since IL-2 induced strong proliferation of
rat thymus cells while IL-5 appeared to have no effect on them. The results of
a limiting dilution analysis of resting B cells exposed to IL-5 are shown in Fig.
5 and Table III. They distinguish two populations of resting B cells responsive
to IL-5. One shows a clone size of one IgM-PFC; these B cells, therefore,
mature without division. Their frequency in the resting B cell population of
C57BL/6 nu/nu mice is between 1 in 50 and 1 in 100. The same population of
resting B cells, in control limiting dilutions with LPS, was shown to contain ^-1
in 10 LPS-reactive B cells (Table III, Fig. 5) .
A second population of B cells proliferate and mature to clones of IgM-secret-
ing cells, with clone sizes of IgM-PFC at day 5 of assay that are near those
observed in LPS-stimulated single B cell clones (Fig. 5). The frequency of this
second population of cells is 15-60 times lower than the first, which matures
without proliferation; i.e., 1 in 1,500-3,000 resting B cells. These results also
indicate that approximately half of the IgM PFC observed in mass cultures of
resting B cells are likely to derive from proliferating B cells (compare total num-
bers of IgM PFC developed in 5 d by the two populations, as shown in Table
III and Fig. 5). We conclude that ^-30% of all resting B cells are LPS reactive,
^-1-2% of them mature without division, and ^-0.03-0.06% proliferate and
mature in the presence of IL-5 .
Discussion
High expression of single ILs in established murine cell lines (Karasuyama, H.
and F. Melchers, submitted for publication) has now allowed a reinvestigation
Numbers of
IgM PFC
per culture*
Number of
cultures
Percent of
total
cultures
Frequency of precursors
forming IgM PFC
predicted by Poisson's
distribution
Frequency of
B cells.
0 492 51 .3 (1/70) 1/50
1 187 19.5 (1/200) 1/130
2 102 10.6 (1/70) 1/50
3 56 5.8 (1/50) 1/35
4 32 3.3 (1/40) 1/27
5 16 1 .7 (1/25) 1/18
5§ 74 7.6 See text 1 .5-3 X 10"KARASUYAMA ET AL.
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of the role of these molecules in responses of normal resting and activated B
cells that, so far, had only been studied with molecules within mixtures with
other activities and, in the best cases, with .only partially purified preparations.
While our preparations of single transformant-made ILs are also only partially
pure, they are, at least, free of other known ILs.
As expected, single rmILs had the biological activities in tests that had been
used to clone the IL genes and express them as active proteins. Thus, mIL-2
stimulated the CTL-L line, mIL-3 stimulated the IC-2 line, while mIL-4 showed
several different biological activities. It induced uptake of radioactive thymidine
in a T cell line, a mast cell progenitor line, and a B cell leukemia line, and stim-
ulated the development of IgGl-secreting cells, while inhibiting that of IgG3-
secreting cells. It is, therefore, all the more remarkable that only two of the four
rILs showed activities in our assays of normal B cell growth and maturation,
particularly since these ILs have all been implicated in some activities on cells
of the B lineage (1-17, 32, 33). IL-2 has been found to be a growth as well as
maturation factor for murine as well as human B cells (4-6, 32, 33). IL-4 (for-
merly BSF-l) has been found to induce increased expression of MHC class II
molecules on B cells, to synergize with Ig-specific antibodies in the stimulation
of resting B cells, to induce specific switching to IgGI and IgE, and to stimulate
pre B cell growth (8-13, 16) (and thymocyte growth [34]). IL-5 has been found
to serve as a late-acting maturation factor not unlike TRF (14, 15, 17), and to
stimulate proliferation as well as maturation of B cells.
The definition of what is a lymphokine for B lymphocytes depends on the
assay used. When we measure the effects on activated B cells, we monitor only
proliferation and, therefore, restrict ourselves to the biological activity of ILs to
promote the progression of B cells through the cell cycle. We monitor this activ-
ity by counting cells. We also monitor maturation, but only as the development
of large numbers of PFC, and only induced in small resting cells. We rely in
both assays on a polyclonal response of a large portion of all B cells. We think
that the LPs-stimulated B blasts belong to the newly formed, short-lived, extra-
follicular, primary B cell subset, while we do not know whether the B cells
induced to maturation without proliferation belong to the same subset.
Although we have also done the experiments that are reported in this paper with
nu/nu spleen cells and with T cell-depleted and A cell-depleted splenic B cells
of normal mice, and have obtained essentially the same results, we cannot
exclude that the mlLs act on a contaminating "non-B" cell population which,
in turn, then acts on resting and/or activated B cells in our assays. Such an
indirect action of mILs is, however, also not ruled out in the other assays quoted
above.
Responses of other LPs-nonreactive B cell populations may go undetected in
our assays of restimulation of LPS-activated B cell blasts in which we monitor
the responses of -10% of all B cells. We assay a 10-fold lower number of B
cells; i.e., 1-2% of all resting B cells, as they mature without proliferation to
PFC, although we do not know whether these 1-2% of all B cells are the same
as the 10% LPS-reactive B cells. Some of the apparent discrepancies may not
only be based on a different readout of the assays, but also be a consequence
of the conditions under which the cells are purified and cultured. We use serum-
substituted cultures and try to enrich B cells as much as possible in an effort to1386
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reduce influences of contaminating cells and factors. Along these lines, high-rate
secretion of single mILs into serum-substituted media, which then can be
diluted much more than the traditional conditioned media, further reduces the
possible influences of unknown contaminations by other activities produced by
the X63-Ag8-653 plasmacytoma cells that secrete the rmILs.
The ideal assay system with which to understand the mechanisms and kinetics
of synergistic B cell control at different restriction points in the cycle (19) would
be to use a single B cell in isolation in defined, serum-substituted media, and
stimulate this single B cell with pure mAbs, pure raBCGF, and pure rmILs. With
the results presented in this paper, we have advanced considerably towards this
goal. Not only does it appear possible to purify large quantities of mILs to
homogeneity, the surprising "filler" activity of mIL-2 and mIL-5 may make it
possible to culture a single B cell in a larger volume of serum-substituted
medium. Experiments along these lines are now in progress.
It is already clear that none of the mILs, either alone or in combinations, can
replace the actions of either anti-Ig antibodies or aBCGF at their respective
restriction points in the cell cycle of an activated B cell. IL-2 and IL-5 both act
as (BCGF at similarly low concentrations that are, in fact, as low as the action
of mIL-2 on the growth of CTL-L cells. This indicates that the interaction of
mIL-2 and mIL-5 with corresponding receptors on activated B cells may be of
high affinity, estimated for T cells to be in the range of 0.01 nM (35) . The struc-
tures of mIL-2 and mIL-5 are sufficiently different to suggest that these two
ligands may have, at least in part, different receptors. Purified preparations,
which we soon hope to have in hand, should then enable us to do receptor-
binding studies to clarify these problems.
While both mIL-2 and mIL-5 are active as BCGF-,Q, they also are BMFs. IL-
2, however, is much weaker than IL-5, which is as active in its BMF activity as
in its BCGF-a activity (i.e., maybe at 0.01 nM). Action of the IL-2-R-specific
mAbs PC61 and 7D4 indicates that mIL-2 and mIL-5 act through different
receptors. The difference in effective concentrations of IL-2 on resting and on
activated B cells could suggest that the receptor for mIL-2 on resting cells is in
a different state, or maybe a different structure, than that on activated B cells.
The limiting dilution analyses performed in this paper indicate that one rest-
ing B cell can mature without proliferation to an IgM PFC. It has been previ-
ously shown (18) that this maturation takes as long; i.e., 5 d of culture, as the
maturation to IgM PFC, which occurs in cultures of polyclonally stimulated pro-
liferating cells and is optimal at day 5. We, therefore, think that the frequencies
determined in Table III will not decrease when the assay is done at earlier or
later times of culture. Frequencies of IL-5-responsive B cells calculated with
Poisson's distribution from the number of cultures with 0, 1, 2, 3, 4, and 5 IgM
PFC in Table III are not exactly the same for all values of IgM PFC and, in fact,
appear to increase with their value. The frequencies calculated from the per-
centage value for one IgM PFC per culture may be lower than expected since
the observation of one PFC is particularly difficult. The frequency increase with
increasing values for IgM PFC could be explained if a minor population of rest-
ing B cells divided once or twice when responding to IL-5. Altogether a value
of 1 in 50 resting B cells responding to IL-5 by maturation without proliferationKARASUYAMA ET AL.
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appears to be a reasonable quantitative estimate from our experimental data.
We have no information whether the IL-5-responsive population of resting B
cells (1-2% of total) is a separate subpopulation and different from that reactive
to LPS or to Ag. It is certainly different from the population of B cells prolif-
erating and maturing in response to IL-5. If occupance of Ig is mandatory for
proliferation of B cells (19), it must be asked what occupies surface Igs of the
IL-5-responsive proliferating B cells. One candidate is Ag in culture, notably
the surface molecules of the rat filler cells, which also are likely to provide a-
type BCGF. It is also conceivable that this minor population of B cells represents
a yet unknown subpopulation that does not follow the rules of B cell growth
control operating with LPS-reactive virgin IgM+ B cells.
A single mIL, IL-5, can induce both maturation and cell cycle progression
through mitosis, i.e., proliferation. This is in agreement with results obtained
with purified IL-5 by Takatsu et al. (21) and appears to settle the question as to
whether one or several factors are involved in these different reactions of a B
cell (19, 36). Final proof will come from a single-cell experiment that now
appears experimentally feasible even in the absence of filler cells, since IL-5 also
acts as a filler activity in maturation assays of B cells (Fig. 4 b).
Since mIL-5 acts with the same apparent high avidity in both reactions, it may
well do so through the same receptor. It is reasonable to expect that it is the
relative position of a B cell in the cell cycle, rather than the nature of the recep-
tor or the ligand, that determines this difference in reaction. A B cell blast in
G2 phase appears to be stimulated by mIL-5 to enter mitosis and end in a phase
of G, where maturation occurs. It should be mentioned that we have not seen
any effect of IFN-y on B cell maturation in our assay system, which previously
has been reported to act synergistically with other helper T cell-derived factors
in the induction to maturation (37) . A resting Go phase B cell appears to be
stimulated by mIL-5 to enter a very similar phase of G,, where maturation
occurs. Both types of B cells can be drawn into the mitotic cycle if anti-Ig anti-
bodies excite them via surface Ig, and if BCGF-a then stimulate them to enter
S phase (19, 29) .
In conclusion, B cells appear to have an option in the G, phase of the cell
cycle either to mature or to enter the mitotic cycle. This duality of reactions has
been observed in LPS-stimulated B cells (30, 38) . The option to either mature
or enter S phase should also be influenced by relative amounts of mIL-2 vs.
mIL-5 available to an activated B cell, where mIL-5 would be more efficient in
driving B cells to maturation.
Summary
Plasmacytoma transformants of the X63-Ag8-653 cell line carrying an expres-
sion vector with either IL-2, -3, -4, or -5 cDNA were established that secrete the
corresponding ILs at high rates. The four mouse ILs (mILs) were then tested
as single ILs and in combinations for their effects on the maturation of resting
and proliferation of activated normal mouse splenic B cells. mIL-3 and mIL-4
were inactive in all assays. mIL-2, as well as mIL-5, synergized with Ig-specific
antibodies and B cell growth factor oc (BCGF-oc) to stimulate successive rounds
of B cell division with LPS-activated B cells. This activity as BCGF-0 was effective1388
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at concentrations similar to those at which mIL-2 induced proliferation of the
CTL-L T cell line, indicating a high-affinity interaction of both mIL-2 and mIL-
5 with their corresponding receptors on activated B cells.
mIL--5 and maybe IL-2 also induced maturation of resting B cells to Ig-secret-
ing cells without proliferation. This B cell maturation factor (BMF) activity of
mIL-5 was as effective as its BCGF-0 activity, while the BMF activity of mIL-2
was at least 102-fold less effective. BMF activity of mIL-2, but not mIL-5, was
blocked by anti-IL-2-R antibodies, indicating that mIL-2 and mIL-5 use separate
receptors far B cell signaling. mIL-2, as well as mIL-5, furthermore, acted as
filler activities when proliferation in the presence of Ig-specific antibodies and
BCGF-a was measured with as little as 500 B cells. In the case of mIL-5, this
was also true for maturation of that few cells. Limiting dilution analyses showed
that ^" 1-2% of the resting B cells matured without division, while 30-100-fold
fewer cells (0 .03-0.06%) proliferated and matured in response to IL-5. A single
IL, therefore, is capable of inducing maturation and of stimulating mitotic cell
cycle progression of normal B cells.
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